98%
921
2 minutes
20
Background: The Catquest questionnaire was developed using traditional methodology to enable cataract surgery outcomes assessment in European countries. Recently, it has been validated using Rasch analysis in a Swedish population resulting in the Catquest-9SF. The aim of the present study was to assess the performance of the Catquest and the Catquest-9SF questionnaires using Rasch analysis in Australian cataract patients.
Methods: A total of 217 cataract patients awaiting surgery at Flinders Medical Centre, Adelaide, South Australia self-administered the Catquest questionnaire. This is a 19-item instrument containing frequency, difficulty, symptoms and global rating items. Rasch analysis was undertaken to assess the unidimensionality (whether all the items are measuring a single underlying construct using principal components analysis or PCA), person separation (ability of the questionnaire to distinguish between strata of patient ability) and targeting of item difficulty to person ability.
Results: Similar to the previous validation study, the original Catquest questionnaire required revision because of misfit and multidimensionality necessitating removal of the frequency items. The revised version was similar to the Catquest-9SF although an extra driving item was a valid optional inclusion. The Catquest-9SF performed well in the Australian cohort satisfying all criteria for valid measurement including unidimensionality. However, targeting of item difficulty to person ability was marginally worse compared with the Swedish cataract population indicating the Australian cataract patients present for surgery at lower levels of visual disability.
Conclusions: The Catquest-9SF is a reliable and valid measure of visual disability in the Australian cataract population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1442-9071.2009.02133.x | DOI Listing |
Clin Ophthalmol
August 2025
Department of Ophthalmology, Tan Tock Seng Hospital, Singapore.
Purpose: To determine the visual performance and patient reported outcomes after bilateral implantation of an enhanced monofocal intraocular lens (IOL) (RayOne EMV RAO200E) targeted for emmetropia or modest monovision.
Patients And Methods: This was a prospective, single-centre, comparative, interventional study. Patients were divided into two groups and targeted for bilateral emmetropia or modest monovision (-1.
Front Med (Lausanne)
June 2025
Oftalvist, Alicante, Spain.
Purpose: To evaluate visual function in eyes with age-related macular degeneration (AMD) implanted with a non-diffractive enhanced depth-of-focus (EDOF) intraocular lens (IOL) after cataract surgery.
Design: Prospective, observational, non-randomized clinical study.
Methods: Twenty-two eyes from 22 patients diagnosed with AMD and cataracts were submitted to standard cataract surgery with a non-diffractive EDOF IOL implantation (AcrySof IQ Vivity).
Int Ophthalmol
June 2025
Department of Ophthalmology, Faculty of Medicine, University Malaya Eye Research Center, University Malaya, Kuala Lumpur, Malaysia.
Objectives: This study aims to compare the outcomes of cataract surgery using Patient reported outcome measures (PROM) between a general tertiary hospital setting and an outreach cataract centre. PROM reports the benefits of surgery from the point of view of the patient instead of a clinical evaluation, which reduces the biases by practitioners.
Methods: Prospective Cohort Analysis.
Eye Vis (Lond)
June 2025
Clinica Baviera-AIER Eye Group, Valencia, Spain.
Background: Patient expectations for post-cataract surgery outcomes have risen. This study aims to evaluate patient satisfaction after bilateral implantation of enhanced monofocal IOL (RayOne EMV RAO200E) designed with positive spherical aberration, used for monovision with a 1.00 D offset.
View Article and Find Full Text PDFJ Clin Med
May 2025
Department of Ophthalmology, Hospital Arruzafa, 14012 Cordoba, Spain.
To evaluate the clinical performance and optical quality of a non-diffractive extended-depth-of-focus (EDOF) intraocular lens (IOL), Asqelio™ EDOF (models ETLIO130C/ETPIO130C), in patients undergoing cataract surgery or refractive lensectomy. This prospective observational, case-control study included patients bilaterally implanted with either the Asqelio™ EDOF IOL (Study Group) or the spherical monofocal TECNIS 1-Piece ZCB00 IOL (Control Group). The postoperative outcomes-at 3 months after surgery-included visual acuities at multiple distances, refraction, contrast sensitivity, the optical scatter index (OSI), wavefront aberrations, and patient-reported outcomes (Catquest-9SF and a quality-of-vision questionnaire).
View Article and Find Full Text PDF